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similar efﬁcacy proﬁle and improvement in safety performance, with a
marked reduction in MI occurrence.
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BACKGROUND Indication of side branch (SB) intervention after main
vessel (MV) stenting is not established in coronary bifurcation lesions.
METHODS In the Coronary Bifurcation Stenting II Registry, 2,897 pa-
tients undergoing percutaneous coronary intervention using drug-
eluting stents for bifurcation lesions with SB 2.3 mm were enrolled.
We selected 2,017 patients treated with 1-stent technique or MV
stenting ﬁrst strategy. Patients undergoing SB intervention after MV
stenting (SB intervention group, n¼929) were compared to those not
after MV stenting (no-SB intervention group, n¼1,088) in terms of
cardiac death or myocardial infarction (MI).
RESULTS During a median follow-up duration of 37 months, the cu-
mulative rate of cardiac death or MI tended to occur less frequently in
the SB intervention group than in the no-SB intervention group (1.8 %
versus 2.9%; adjusted hazard ratio [HR] 0.56; 95% conﬁdence interval
[CI] 0.29 to 1.07; p¼0.08). There was signiﬁcant interaction between
SB intervention and SB stenosis after MV stenting (p for
interaction <0.01). Of 1,077 patients with diameter stenosis of
SB 50% after MV stenting, SB intervention was associated with a
lower risk of cardiac death or MI (1.2% versus 4.2%; adjusted HR 0.22;
95% CI 0.09 to 0.52; p<0.01). However, among 940 patients with
diameter stenosis of SB <50%, there was no signiﬁcant difference in
cardiac death or MI (3.5% versus 2.2%; adjusted HR 1.36; 95% CI 0.58
to 3.20; p¼0.48) between the two groups.
Table 5. Clinical Outcomes according to residual SB stenosis after MV stenting.SB
interventionNo SB
intervention Unadjusted HRp value1Adjusted HR p
value
(n[670) (n[407) (95% CI) (95% CI)Patients with DS of SB 50% after MV stenting (n¼1,077)
Cardiac death
or MI8 (1.2) 17 (4.2) 0.24 (0.11-0.57) 0.001 0.22 (0.09-0.52) 0.001TLR 53 (7.9) 26 (6.4) 1.07 (0.67-1.71) 0.784 1.04 (0.64-1.68) 0.880SB
interventionNo SB
intervention Unadjusted HRp value2Adjusted HR p
value
(n[259) (n[681) (95% CI) (95% CI)Patients with DS of SB <50% after MV stenting (n¼940)
Cardiac death
or MI9 (3.5) 15 (2.2) 1.50 (0.66-3.43) 0.338 1.36 (0.58-3.20) 0.475TLR 12 (4.6) 35 (5.1) 0.85 (0.44-1.63) 0.620 0.80 (0.41-1.56) 0.510CI ¼ conﬁdence interval; DS ¼ diameter stenosis; HR ¼ hazard ratio; MI ¼ myocardial infarction; MV ¼ main
vessel; SB ¼ side branch; TLR ¼ target lesion revascularization.1Adjusted covariates included bifurcation
location, true bifurcation and MV lesion length before procedure.
2
Adjusted covariates included history of
previous PCI, acute coronary syndrome, and true bifurcation.
CONCLUSIONS Effect of SB intervention seems to differ according to
SB stenosis after MV stenting. SB intervention may reduce cardiac
death or MI in bifurcation lesions with diameter stenosis of SB 50%
after MV stenting.
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BACKGROUND It is unclear whether the routine follow up (FU) cor-
onary angiography (CAG) regardless of patient’s symptoms after suc-
cessful percutaneous coronary intervention (PCI) with drug-eluting
stents (DESs) in patients (pts) with multi-vessel disease (MVD) is
beneﬁcial or not.
METHODS The study population consisted of 642 consecutive MVD
pts underwent PCI with unrestricted utilization of DESs from January
2004 to May 2011. Routine FU CAG was performed between 6 to 9
months following index PCI and was decided by individual physi-
cian’s discretion. Rests of the pts were clinically followed and
ischemic driven events were captured. Clinical events including
mortality, myocardial infarction and clinically driven PCI before 9
months were excluded in both groups. Cumulative clinical outcomes
up to 3 years were compared between the Routine CAG group (n¼374
pts) and the Clinical FU group (n¼ 268 pts). To adjust potential con-
founders, a propensity score matched (PSM) analysis was performed
using the logistic regression model.
RESULTS After PSM analysis, 2 propensity-matched groups (193 pairs,
n ¼ 386 pts, C-statistic¼0.744) were generated and the baseline
characteristics of the two groups were balanced. At 3 years, the inci-
dence of target lesion revascularization (TLR) and target vessel
revascularization (TVR) and major adverse cardiac events (MACEs)
was higher in the Routine CAG group than the control group (Table).
CONCLUSIONS Despite the expected beneﬁcial effects, routine FU
CAG following index PCI with DESs in MVD pts was associated with
higher incidence of repeat PCI including TLR and TVR and MACE up to
3 years.
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BACKGROUND ACC/AHA coronary lesion classiﬁcation was devel-
oped in 1988 as a method of predicting procedural success and
complications in the angioplasty era. Correlation with short- and
medium-term outcomes during the contemporary percutaneous cor-
onary intervention (PCI) era is not well established. We aimed to
J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y , V O L . 6 6 , N O . 1 5 , S U P P L B , 2 0 1 5 B193assess whether the ACC/AHA lesion classiﬁcation continues to
predict in-hospital, 30-day, and 12-month clinical outcomes in
contemporary PCI.
METHODS We analyzed clinical characteristics and outcomes ac-
cording to ACC/AHA lesion classiﬁcation (A, B1, B2, C) in 13,701 PCI
cases from the Melbourne Interventional Group (MIG) registry. Pa-
tients presenting with STEMI, cardiogenic shock and out of hospital
cardiac arrest were excluded. We assessed in-hospital, 30-day, and 12-
month clinical outcomes based on ACC/AHA lesion classiﬁcation.
RESULTS Patients with type C lesions (18%) were more likely to be
older and have impaired renal function, diabetes, previous myocardial
infarction, peripheral vascular disease and prior bypass graft surgery
(all p<0.01). Type C lesions were more likely to be bifurcation, ostial
and chronic total occlusions and required larger sheath sizes (>6
French), rotational atherectomy, drug-eluting stents and longer stent
length (all p<0.01).A (n[1246) B1 (n[5519) B2 (n[4449) C (n[2487) P-valueSuccess 99.6% 99.1% 96.6% 82.7% <0.01Perforation 0.1% 0.2% 0.1% 0.9% <0.01No reﬂow 1.7% 1.5% 3.2% 3.9% <0.01Unplanned CABG 0.1% 0.1% 0.7% 1.9% <0.01Inhospital Bleeding 1.8% 1.4% 1.5% 1.7% 0.7230-day MACE 2.1% 2.0% 3.8% 6.3% <0.0112-month MACE 9.2% 9.9% 12.9% 16.5% <0.01CONCLUSIONS ACC/AHA lesion classiﬁcation is still relevant and
predictive of in-hospital and long-term outcomes, and should still be
calculated pre-procedure to predict PCI success and outcomes.
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BACKGROUND Although percutaneous coronary intervention (PCI) of
chronic total occlusion (CTO) lesions commonly require ’full metal
jacket’(FMJ, stent length  60mm without gaps) procedure to cover
full coronary artery lesions, long-term clinical outcomes after FMJ
procedure in CTO lesions remain largely unknown.
METHODS From Asan Medical Center-CTO registry, 388 consecutive
patients treated with FMJ procedure and 719 with non-FMJ procedure
were identiﬁed. The primary endpoint was the incidence of major
adverse cardiac events (MACE) deﬁned as a composite of death,
Q-wave myocardial infarction (MI), or target-vessel revascularization
(TVR).
RESULTS During a median follow-up of 4.5-years, the cumulative
incidence of all-death were not signiﬁcantly different between pa-
tients who underwent FMJ and non-FMJ procedure (9.1% vs. 8.4%,
P¼0.51). After adjusting confounders, there was no signiﬁcant differ-
ence between patients who received FMJ and non-FMJ procedure for
the risk of MACE. (Hazard ratio [HR] 1.19, 95% conﬁdence interval [CI]
0.80-1.75, P¼0.39). The adjusted risk of death (HR 1.28, 95% CI 0.78-
2.12, P ¼0.33), Q-wave MI (HR 0.93, 95% CI 0.30-2.89, P ¼0.90) and
TVR (HR 1.22, 95% CI 0.63-2.37, P¼0.56) were similar between the two
groups. The incidence of deﬁnite/probable stent thrombosis was
comparable (1.6% vs.1.1%, P¼0.58) throughout the follow-up period.CONCLUSIONS The 4.5-year clinical outcomes of patients after CTO-
PCI with FMJ procedure were comparable from those with non-FMJ
procedure.
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BACKGROUND The SYNTAX study showed signiﬁcant improvement
in the efﬁcacy of PCI using 1st generation DES for unprotected left
main coronary artery (LMCA) disease. It has been proposed that the
2nd generation DES will provide better PCI outcomes for LMCA
compared with SYNTAX trial. In Japan, PCI was frequently conducted
with the guidance of IVUS. These procedural characteristics may
further contribute to the improvement of PCI outcomes for LMCA.
METHODS J-Lesson is a prospective, single arm, open study that
enrolled 441 unprotected LMCA treated with everolimus eluting drug
eluting stent (EES) at 54 institutes in Japan. SYNTAX score and
quantitative coronary angiogram was evaluated by independent core-
laboratory. Primary end point of the present study was major adverse
cardio-cerebrovascular event (MACCE) and MACCEþTVF was sec-
ondary end point. It is scheduled to follow-up for 5 years.
RESULTS In baseline characteristics, 40.4 % was DM and 36.8 % of the
subjects had a history of PCI. The history of MI, stroke and PAD was
observed in 18%, 8.9%, and 7.5%, respectively. Subjects were subdivided
according to SYNTAX score (Low<23 n¼202, Intermediate 23-32 n¼146,
High>32 n¼81). Euroscore 3-5 was 45.4% and >6 was 24.9%. IVUS guided
PCI was underwent in 97.5%. Number of stent/lesion was 1.3 and mean
stent lengthwas29.3mm. Interimanalysis of 373pts (84.6%)demonstrated
that MACCE rate at 2 year was 3.9% (2.1-5.75) and no difference among 3
different SYNTAX score group. MACCEwas also not different according to
EuroSCORE. MACCEþTLR at 2 year was signiﬁcantly higher in SYNTAX
high group compared with the other 2 groups (SYNTAX low 4.5%, inter-
mediate 8.9%, high 19.8%) and did not differ among 3 groups. Complete
follow-up data will be available at TCT 2015.
CONCLUSIONS The J-lesson registry demonstrated clinical outcomes of
PCI for LMCA with the combination use of 2nd generation DES and IVUS.
The present outcomes support the clinical efﬁcacy of PCI for LMCA. In
addition, SYNTAX score is useful tool to discriminate the future revascu-
larization risk, but could not discriminate the MACCE risk.
